Related Experiment Video
Updated: Jul 16, 2026
09:48
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Gynaecological malignancies in pregnancy
1Addenbrooke's Hospital, Cambridge, UK. jal70@cam.ac.uk
Current Opinion in Obstetrics & Gynecology
|March 14, 2007
Summary
Managing gynecological cancers during pregnancy is rare but challenging. Prolonging pregnancy for fetal viability is possible, with favorable outcomes for most mothers and babies.
Area of Science:
- Gynecologic Oncology
- Reproductive Medicine
- Maternal-Fetal Medicine
Background:
- Gynecological cancers are rarely diagnosed during pregnancy.
- Management decisions often rely on limited case series and reports.
- This review synthesizes current knowledge on managing these complex cases.
Purpose of the Study:
- To review the management of gynecological cancers in pregnancy.
- To analyze the bidirectional impact of cancer on pregnancy and vice versa.
- To provide insights for multidisciplinary care teams.
Main Methods:
- Literature review of case reports and series.
- Analysis of outcomes in women with gynecological malignancies during gestation.
- Discussion of strategies for optimizing maternal and fetal well-being.
Main Results:
- Gynaecological cancers in pregnancy present rare but significant management challenges.
- Successful prolongation of pregnancy for fetal viability has been reported for cervical and ovarian cancers.
- Evidence suggests that many cases have favorable outcomes for both mother and child.
Conclusions:
- Cancer during pregnancy is a critical event requiring multidisciplinary team collaboration.
- Women face significant emotional distress regarding fetal survival and future fertility.
- Despite challenges, outcomes for most women and their infants are generally favorable.
Related Concept Videos
01:24Disorders of the Female Reproductive System
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
02:07Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:27Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...